EMSAM (Mylan Specialty L.P.)


Welcome to the PulseAid listing for the EMSAM drug offered from Mylan Specialty L.P.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Specialty L.P.
NON-PROPRIETARY NAME: selegiline
SUBSTANCE NAME: SELEGILINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-02-27
END MARKETING DATE: 0000-00-00


EMSAM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEMSAM from Mylan Specialty L.P.
LABELER NAME: Mylan Specialty L.P.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/24h)
START MARKETING DATE: 2006-02-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49502-900_5e530449-b3e9-4f49-a15d-a86e30a65c3c
PRODUCT NDC: 49502-900
APPLICATION NUMBER: NDA021336

Other SELEGILINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Specialty L.P.EMSAM